OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection
Synat Keam, Dewi Megawati, Shailesh Kumar Patel, et al.
Reviews in Medical Virology (2020) Vol. 30, Iss. 5
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Remdesivir and its antiviral activity against COVID-19: A systematic review
Andri Frediansyah, Firzan Nainu, Kuldeep Dhama, et al.
Clinical Epidemiology and Global Health (2020) Vol. 9, pp. 123-127
Open Access | Times Cited: 206

Covid‐19 and dengue: Double punches for dengue‐endemic countries in Asia
Harapan Harapan, Mirza Ryan, Benediktus Yohan, et al.
Reviews in Medical Virology (2020) Vol. 31, Iss. 2
Open Access | Times Cited: 187

Antivirals for COVID-19: A critical review
Andri Frediansyah, Ruchi Tiwari, Khan Sharun, et al.
Clinical Epidemiology and Global Health (2020) Vol. 9, pp. 90-98
Open Access | Times Cited: 171

An overview on the treatments and prevention against COVID-19
Yunes Panahi, Armita Mahdavi Gorabi, Sona Talaei, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 48

Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection
Hossein Khorramdelazad, Mohammad Hossein Kazemi, Alireza Najafi, et al.
Microbial Pathogenesis (2020) Vol. 152, pp. 104554-104554
Open Access | Times Cited: 116

Geriatric Population During the COVID-19 Pandemic: Problems, Considerations, Exigencies, and Beyond
Kuldeep Dhama, Shailesh Kumar Patel, Rakesh Kumar, et al.
Frontiers in Public Health (2020) Vol. 8
Open Access | Times Cited: 94

Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects
Khan Sharun, Ruchi Tiwari, Mohd. Iqbal Yatoo, et al.
Expert Opinion on Biological Therapy (2020) Vol. 20, Iss. 9, pp. 1033-1046
Closed Access | Times Cited: 79

Immunotherapeutic approaches to curtail COVID-19
Hajar Owji, Manica Negahdaripour, Nasim Hajighahramani
International Immunopharmacology (2020) Vol. 88, pp. 106924-106924
Open Access | Times Cited: 75

SARS-CoV-2 reinfection and implications for vaccine development
Firzan Nainu, Rufika S. Abidin, Muh. Akbar Bahar, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 12, pp. 3061-3073
Open Access | Times Cited: 71

SARS-CoV-2 infection during pregnancy and pregnancy-related conditions: Concerns, challenges, management and mitigation strategies–a narrative review
Rakesh Kumar, Cut Meurah Yeni, Niken Asri Utami, et al.
Journal of Infection and Public Health (2021) Vol. 14, Iss. 7, pp. 863-875
Open Access | Times Cited: 70

Plant-based vaccines and antibodies to combat COVID-19: current status and prospects
Kuldeep Dhama, Senthilkumar Natesan, Mohd. Iqbal Yatoo, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 12, pp. 2913-2920
Open Access | Times Cited: 55

β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19
Niraj Kumar Jha, Charu Sharma, Hebaallah Mamdouh Hashiesh, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 53

Can Echinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019
Mohamed Fizur Nagoor Meeran, Hayate Javed, Charu Sharma, et al.
Heliyon (2021) Vol. 7, Iss. 2, pp. e05990-e05990
Open Access | Times Cited: 48

The Immunopathology of COVID-19 and the Cannabis Paradigm
Nicole Paland, Antonina Pechkovsky, Miran Aswad, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 40

A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19
Khan Sharun, Ruchi Tiwari, Mohd I. Yatoo, et al.
Narra J (2022) Vol. 2, Iss. 3, pp. e92-e92
Open Access | Times Cited: 34

Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application
Nana Tao, Xie George Xu, Yuyuan Ying, et al.
Molecules (2023) Vol. 28, Iss. 8, pp. 3539-3539
Open Access | Times Cited: 15

Herbal Medicines as Complementary Therapy for Managing Complications in COVID-19 Patients with Diabetes Mellitus
Syah Akbarul Adha, Nadiya Nurul Afifah, Irma Rahayu Latarissa, et al.
Diabetes Metabolic Syndrome and Obesity (2025) Vol. Volume 18, pp. 135-146
Open Access

SARS-CoV-2 existence in sewage and wastewater: A global public health concern?
Kuldeep Dhama, Shailesh Kumar Patel, Mohd. Iqbal Yatoo, et al.
Journal of Environmental Management (2020) Vol. 280, pp. 111825-111825
Open Access | Times Cited: 40

Global prevalence and pathogenesis of headache in COVID-19: A systematic review and meta-analysis
Endang Mutiawati, Syahrul Syahrul, Marhami Fahriani, et al.
F1000Research (2020) Vol. 9, pp. 1316-1316
Open Access | Times Cited: 40

Page 1 - Next Page

Scroll to top